# Patient Preference Study

> **NCT00576342** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 129 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** AL-3862+timolol ophthalmic suspension
- **DRUG:** Dorzolamide+timolol ophthalmic solution

## Key facts

- **NCT ID:** NCT00576342
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2014-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576342, "Patient Preference Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00576342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*